India to ban antibiotic pollution from pharma factories
The Indian government is to limit the amount of antibiotic residue permitted in wastewater released by drug factories, after a series of stories by the Bureau of Investigative Journalism.
A draft bill published on 23 January introduces limits on the concentrations of antibiotics found in the waste discharged by pharmaceutical factories into rivers and the surrounding environment. Experts believe anything above these limits fuels the creation of drug-resistant bacteria, or superbugs.
The growth in superbugs is one of the biggest public health crises facing the world today. Nearly 60,000 newborns a year die from superbug infections in India. If resistance keeps rising people could once again die from common infections, while procedures such as Caesareans, hip replacements and chemotherapy could become impossible to carry out.
Boosting innovation in AMR?
15 OCT 2020: online Kick Off event AMR Innovation Mission UK 2021
The AMR Innovation Mission UK 2020/2021 aims to add to the global curbing of AMR by boosting joint early & translational research, R&D, clinical development, validation, registration and commercialisation of vaccines, microbial diagnostics and antimicrobial products.